Jiangsu Hengrui Medicine
600276.SS
#469
Rank
A$66.82 B
Marketcap
$10.48
Share price
-1.00%
Change (1 day)
0.35%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Cash on Hand

Cash on Hand as of September 2024 : A$4.96 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company has A$4.96 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Jiangsu Hengrui Medicine - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$3.80 B-6.04%
2021-12-31A$4.05 B23.68%
2020-12-31A$3.27 B18.16%
2019-12-31A$2.77 B20.4%
2018-12-31A$2.30 B174.16%
2017-12-31A$0.84 B-14.39%
2016-12-31A$0.98 B-9.73%
2015-12-31A$1.08 B59.74%
2014-12-31A$0.68 B69.38%
2013-12-31A$0.40 B95.84%
2012-12-31A$0.20 B39.28%
2011-12-31A$0.14 B-0.56%
2010-12-31A$0.14 B28.53%
2009-12-31A$0.11 B19.1%
2008-12-31A$96.78 M-26.84%
2007-12-31A$0.13 B41.2%
2006-12-31A$93.69 M28.2%
2005-12-31A$73.08 M28.62%
2004-12-31A$56.81 M73.63%
2003-12-31A$32.72 M-20.26%
2002-12-31A$41.04 M-36.03%
2001-12-31A$64.15 M-38.61%
2000-12-31A$0.10 B472.85%
1999-12-31A$18.24 M223.03%
1998-12-31A$5.64 M15.62%
1997-12-31A$4.88 M